DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oxamniquine
Oxamniquine
Trs
Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T
Comparative Genomics of the Major Parasitic Worms
Drug-N-Therapeutics-Committee.Pdf
Anthelmintics Are Drugs Used to Treat Parasitic Infections Due to Worms
World Health Organization Model List of Essential Medicines, 21St List, 2019
The Selection of Essential Drugs
Anthelmintics-Copy-150901012905
WO 2014/053555 Al 10 April 2014 (10.04.2014) P O P C T
Studies of the Mode of Action of Anthelmintic Drugs: Tools to Investigate the Biochemical Pecularities of Helminths H
Review of Existing Classification Efforts
Association of Oxamniquine Praziquantel and Clonazepam in Experimental Schistosomiasis Mansoni
TRENDS in the DEVELOPMENT of CHEMOTHERAPY for PARASITIC DISEASES ~ I I KEITH ARNOLD I Roche Far East Research Foundation, Hong Kong
Metrifonate(BAN, Rinn)
The Selection and Use of Essential Medicines
Drugs for Parasitic Infections (2013 Edition)
(12) United States Patent (10) Patent No.: US 6,638,528 B1 Kanios (45) Date of Patent: Oct
Top View
WHO Model List of Essential Medicines
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Manufacturers of Drugs Used to Treat Parasitic
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
The Medical Letter
Side-Effects Reported in Studies Found Through Supplementary Searching of Treatment with Albendazole, Niclosamide Or Praziquantel of Other Parasites
Customs Tariff - Schedule Xxi - 1
The Most Common Prescription Drugs Used to Treat Intestinal Parasite Infe
Oxamniquine Resistance Alleles Are Widespread
Treatment of Cutaneous Larva Migrans with Ivermectin
TRS 917, Annex 1
Investigation on the Binding Affinities of Different Anthelmintic Drugs On
(12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
Oxamniquine, Praziquantel and Lovastatin Association in the Experimental Schistosomiasis Mansoni
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Oxamniquine Resistance Alleles Are Widespread in Old World
Mesh Terms for 2002
18Th Expert Committee on the Selection and Use of Essential Medicines Reviewer No
Ninth Meeting of the Working Group on Monitoring of Neglected Tropical Diseases Drug Efficacy
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
ICD-10-CM Table of Drugs 2019
(19) United States (12) Patent Application Publication (10) Pub
The Medical Letter
Anthelminthic Agents: Some Recent Developments and Their Clinical Application* G.C
The Selection and Use of Essential Medicines
CHPI Program-2013 FINAL Bpssv2
Efficacy of Oxamniquine and Praziquantel in the Treatment of Schistosoma Mansoni Infection: a Controlled Trial M.L.A
A Machine-Learning Approach Through Data Integration
(12) United States Patent (10) Patent No.: US 8,628,794 B2 Sele (45) Date of Patent: Jan
Resolution Ap (2000) 1
Application for Classification of Albendazole 200Mg Tablets to General Medicine As an Anthelmintic in Total Doses Not Exceeding 400Mg